Columvi 10 mg/10mL
Glofitamab · CONCENTRATE · Genentech, Inc.
No Recall History
Plain English
Columvi is a concentrate containing glofitamab at 10 mg/10mL, taken intravenous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Columvi
- Generic Name
- Glofitamab
- NDC Code (Product)
50242-127- Manufacturer
- Genentech, Inc.
- Strength
- 10 mg/10mL
- Dosage Form
- CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761309
- Drug Class
- Bispecific CD20-directed CD3 T Cell Engager [EPC]
- Marketing Start
- 06/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Columvi used for?
Columvi contains Glofitamab. It is a concentrate taken intravenous. Consult your doctor for specific uses.
Is Columvi a controlled substance?
Columvi is not classified as a controlled substance by the DEA.
What is the generic name for Columvi?
The generic name for Columvi is Glofitamab. There are no other listed brand versions of Glofitamab.
What is the NDC code for Columvi 10 mg/10mL?
The NDC (National Drug Code) for Columvi 10 mg/10mL is 50242-127, listed by Genentech, Inc..
Other Columvi Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)